DMK

DMK Pharmaceuticals Corporation Common Stock
DMK

Overview Fund Activity
Delisted

DMK was delisted on the 6th of February, 2024.

Back to rankings

21 hedge funds and large institutions have $5.65M invested in DMK Pharmaceuticals Corporation Common Stock in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 8 closing their positions.

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
3
Closed
8
Calls
$65K
Puts
$10K
Net Calls
+$55K
Net Calls Change
+$37K

Top Buyers

1
GP
1
Grow Partners
California
$2.43M
2
HighTower Advisors
2
HighTower Advisors
Illinois
$317K
3
Northern Trust
3
Northern Trust
Illinois
$112K
4
BIT
4
BlackRock Institutional Trust
California
$218K
5
Goldman Sachs
5
Goldman Sachs
New York
$409K

Top Sellers

1
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
$0
2
DCM
2
DAFNA Capital Management
California
$0
3
SM
3
Sabby Management
Florida
$0
4
PCM
4
Prelude Capital Management
New York
$0
5
SM
5
Scoggin Management
New York
$422K
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
– – -454 Closed
PNC Financial Services Group
27
PNC Financial Services Group
Pennsylvania
– – -77 Closed
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$0 4 -1 -20%
TRCT
29
Tower Research Capital (TRC)
New York
$0 71 +71 New
1
2